LambdaTest Announces Seamless Azure DevOps Integration for Effortless Test Management
New Azure DevOps App From LambdaTest streamlines Test Management, enhancing collaboration and efficiency with AI-driven test case creation, tracking, and seamless integration.
LambdaTest, a GenAI-powered quality engineering platform, is excited to announce the launch of its Azure DevOps App, designed to streamline test management within the Azure DevOps environment. The LambdaTest Azure DevOps App integrates directly with Azure DevOps through the Azure DevOps Marketplace, providing users with a powerful tool to manage and track their executions. They can also link test cases, track executions of those test cases, and create new test cases with AI or manually in a seamless manner, boosting workflow efficiency and fostering better collaboration across development teams.
The LambdaTest AI Test Manager, which is available through the Azure DevOps Marketplace, enhances the Azure DevOps interface by bringing test management functionalities right where teams are already working. This direct integration allows developers and testers to efficiently handle test cases, whether creating, linking, or tracking them, without switching between different tools or environments.
LambdaTest’s Azure DevOps App offers effortless setup via the Azure DevOps Marketplace with simple authentication. It enables seamless linking of test cases to work items for clear traceability. Users can leverage AI to create contextual test cases by entering requirements or uploading files directly within Azure DevOps. The app provides detailed execution history for visibility into test results and supports easy sharing and review of test cases, enhancing collaboration. This integration streamlines workflows and strengthens coordination between development and testing teams.
"We believe that this integration will significantly enhance the development workflow for our users," said Mayank Bhola, Co-Founder & Head of Products of LambdaTest. "By bringing together test management and Azure DevOps in one platform, teams can now test more efficiently and deliver high-quality products faster. This is yet another step in our mission to streamline the testing process and support seamless CI/CD pipelines across organizations."
LambdaTest’s integration with Azure DevOps is a game changer for organizations looking to enhance their testing workflow. By reducing friction between development and testing, this integration allows teams to accelerate releases while maintaining high-quality standards.
The LambdaTest Azure DevOps App is available now in the Azure DevOps Marketplace, providing teams with an intuitive, all-in-one solution for managing tests within their existing DevOps workflow.
For more information on LambdaTest Azure DevOps App, please visit https://www.lambdatest.com/blog/ai-test-manager-azure-devops-extension/
About LambdaTest
LambdaTest is a GenAI-powered Quality Engineering Platform that empowers teams to test intelligently, smarter, and ship faster. Built for scale, it offers a full-stack testing cloud with 10K+ real devices and 3,000+ browsers.
With AI-native test management, MCP servers, and agent-based automation, LambdaTest supports Selenium, Appium, Playwright, and all major frameworks. AI Agents like HyperExecute and KaneAI bring the power of AI and cloud into your software testing workflow, enabling seamless automation testing with 120+ integrations.
LambdaTest Agents accelerate your testing throughout the entire SDLC, from test planning and authoring to automation, infrastructure, execution, RCA, and reporting.
For more information, please visit https://lambdatest.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250729099836/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Logitech Announces Q1 Fiscal Year 2026 Results29.7.2025 22:02:00 CEST | Press release
Strong First Quarter Underscores Company’s Superior Innovation and Operational Excellence SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the first quarter of Fiscal Year 2026. Sales were $1.15 billion, up 5 percent in US dollars and 5 percent in constant currency, compared to Q1 of the prior year. GAAP gross margin was 41.7 percent, down 110 basis points, compared to Q1 of the prior year. Non-GAAP gross margin was 42.1 percent, down 120 basis points, compared to Q1 of the prior year. GAAP operating income was $162 million, up 6 percent, compared to Q1 of the prior year. Non-GAAP operating income was $202 million, up 11 percent, compared to Q1 of the prior year. GAAP earnings per share (EPS) was $0.98, up 7 percent compared to Q1 of the prior year. Non-GAAP EPS was $1.26, up 12 percent compared to Q1 of the prior year. Cash flow from operations was $125 million. The quarter-ending ca
Cooler Master Announces North American Availability of MasterFrame 500 Mesh29.7.2025 21:44:00 CEST | Press release
Open-frame, high-airflow ATX chassis with dual 200 mm fans, dual 360 mm radiator support, and serious mod potential lands August 19 Cooler Master, a global leader in innovative thermal solutions and PC hardware, today announced North American availability of the MasterFrame 500 Mesh, a premium open-frame ATX chassis built for extreme cooling and straightforward customization. Developed under Cooler Master’s FreeForm 2.0 design philosophy, it gives builders the structure, airflow, and files they need to tailor the frame to their vision. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250729317532/en/ Cooler Master MasterFrame 500 Mesh PC Case The chassis features an exposed exo-structure, mesh panels for stronger airflow, support for Mini-ITX to E-ATX motherboards, and GPU clearance up to 390 mm. ARGB and non-ARGB versions both ship with dual SickleFlow 200 mm front fans and a 120 mm rear fan. With room for up to eight fans an
Rigaku Launches XTRAIA XD-3300 Mass Production for Semiconductor Market29.7.2025 16:00:00 CEST | Press release
Accelerating Next-Gen Memory and Logic with Ultrafast, Non-Destructive Metrology Rigaku Corporation, a global solution partner in X-ray metrology systems and a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”), has launched full-fledged commercial production of XTRAIA XD-3300, a high-resolution microspot X-ray diffraction system This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250729915168/en/ XTRAIA XD-3300 Against a background of demand for generative AI and data centers, scaling and 3D realization of semiconductors are advancing at unprecedented speed. Needs are growing for next-generation memory such as high-bandwidth memory (HBM) and 3D DRAM as well as 2 nm and subsequent generations of logic semiconductor. To secure high performance in these devices, chipmakers are increasingly adopting superlattices (nanoscale integrated structures) using Si/SiGe (silic
AQNEURSA® (levacetylleucine) Recommended for EU Approval by the CHMP to Treat Niemann-Pick Disease Type C29.7.2025 15:27:00 CEST | Press release
AQNEURSA® could offer a new frontline treatment for NPC patients in EuropeCHMP recommendation based on Phase III pivotal trial data and extension phase data, showing rapid symptomatic improvement, long-term benefit, and disease-modifying, neuroprotective effects1,2European Commission decision will follow later this yearAQNEURSA previously received U.S. FDA approval in September, 2024 IntraBio Inc., a biopharmaceutical company focused on developing therapies for rare neurological diseases, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of AQNEURSA® (levacetylleucine) for the treatment of Niemann-Pick disease type C (NPC). "This positive CHMP opinion represents another important milestone in expanding access to AQNEURSA to the global NPC community," said Dr. Marc Patterson, Chief Medical Officer of IntraBio. "The recommendation reflects the strength of our clinical data a
NetJets Empowers Pilots With Cutting-Edge Safety Analytics From FlightPulse®29.7.2025 15:05:00 CEST | Press release
The company is the first shared ownership provider to implement the application, giving its aviators access to indispensable safety and operational data. Recognized worldwide for its safety-first focus, NetJets, the global private aviation leader, today announced the adoption of FlightPulse® from GE Aerospace across its operations in the United States and Europe, providing pilots with data to increase safety and efficiency from takeoff to landing. FlightPulse® will equip NetJets’ more than 4,400 pilots globally with secure, consolidated flight data to drive informed decisions on risk management, aircraft functionality and fuel, and their own performance, fostering continuous self-improvement. NetJets is the first private jet operator of its kind to embrace the technology, which it plans to begin deploying by the end of the year. “In the world of aviation, safety is paramount and will always be NetJets’ first and highest priority, integral to every decision we make,” said Adam Johnson,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom